Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo

Carcinoids are slow-growing neuroendocrine tumors (NETs) that are characterized by hormone overproduction; surgery is currently the only option for treatment. Activation of the Notch pathway has previously been shown to have a role in tumor suppression in NETs. The marine-derived thiodepsipeptide thiocoraline was investigated in vitro in two carcinoid cell lines (BON and H727). Carcinoid cells treated with nanomolar concentrations of thiocoraline resulted in a decrease in cell proliferation and an alteration of malignant phenotype evidenced by decrease of NET markers, achaete-scute complex like-1, chromogranin A and neurospecific enolase. Western blotting analysis demonstrated the activation of Notch1 on the protein level in BON cells. Additionally, thiocoraline activated downstream Notch targets HES1, HES5 and HEY2. Thiocoraline effectively suppressed carcinoid cell growth by promoting cell cycle arrest in BON and H727 cells. An in vivo study demonstrated that thiocoraline, formulated with polymeric micelles, slowed carcinoid tumor progression. Thus the therapeutic potential of thiocoraline, which induced activation of the Notch pathway, in carcinoid tumors was demonstrated.

• Publication year

  2014

• Venue

  Cancer Gene Therapy

• Publication date

  2014-10-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/cgt.2014.57PMID 25412645PMCID 4270822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cotargeting the PI3K and RAS Pathways for the Treatment of Neuroendocrine Tumors

  2014cited by this paper
• Enzyme-labile protecting groups for the synthesis of natural products: solid-phase synthesis of thiocoraline.

  2013cited by this paper
• Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line

  2013cited by this paper
• Liposomes as drug deposits in multilayered polymer films.

  2013cited by this paper
• Myoblast Cell Interaction with Polydopamine Coated Liposomes

  2012cited by this paper
• Comparative Stability Studies of Poly(2-methyl-2-oxazoline) and Poly(ethylene glycol) Brush Coatings

  2012cited by this paper
• First natural analogs of the cytotoxic thiodepsipeptide thiocoraline A from a marine Verrucosispora sp.

  2011cited by this paper
• A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs.

  2011cited by this paper
• Characterization of TioQ, a type II thioesterase from the thiocoraline biosynthetic cluster.

  2011cited by this paper
• Expression of the active Notch1 decreases MTC tumor growth in vivo.

  2011cited by this paper
• A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.

  2011cited by this paper
• Hesperetin, a potential therapy for carcinoid cancer.

  2011cited by this paper
• A new scaffold of an old protein fold ensures binding to the bisintercalator thiocoraline.

  2010cited by this paper
• TioS T‐TE – a prototypical thioesterase responsible for cyclodimerization of the quinoline‐ and quinoxaline‐type class of chromodepsipeptides

  2009cited by this paper
• Carcinoid tumors.

  2008cited by this paper
• Characterization of TioF, a tryptophan 2,3-dioxygenase involved in 3-hydroxyquinaldic acid formation during thiocoraline biosynthesis.

  2008cited by this paper
• Fermentation , Isolation and Biological Activities

  2008cited by this paper
• Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.

  2007cited by this paper
• Antitumor activity, X-ray crystal structure, and DNA binding properties of thiocoraline A, a natural bisintercalating thiodepsipeptide.

  2007cited by this paper
• In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer

  2006cited by this paper
• Deciphering the Biosynthesis Pathway of the Antitumor Thiocoraline from a Marine Actinomycete and Its Expression in Two Streptomyces Species

  2006cited by this paper
• Carcinoid Tumors

  2006cited by this paper
• Overexpression of the NOTCH1 Intracellular Domain Inhibits Cell Proliferation and Alters the Neuroendocrine Phenotype of Medullary Thyroid Cancer Cells*

  2006cited by this paper
• Notch signalling: a simple pathway becomes complex

  2006cited by this paper
• Carcinoid tumors.

  2006cited by this paper
• Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells.

  2005cited by this paper
• ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells

  2005cited by this paper
• Epidemiology of Neuroendocrine Tumours

  2004cited by this paper
• FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC)

  2003cited by this paper
• A 5‐decade analysis of 13,715 carcinoid tumors

  2003cited by this paper
• Carcinoid A Comprehensive Review

  2003cited by this paper
• Notch Signaling in Cancer

  2002cited by this paper
• Transactivation of Repair Genes by BRCA1

  2002cited by this paper
• Total syntheses of thiocoraline and BE-22179 and assessment of their DNA binding and biological properties.

  2001cited by this paper
• Total Syntheses of Thiocoraline and BE-22179: Establishment of Relative and Absolute Stereochemistry

  2000cited by this paper
• Total Syntheses of Thiocoraline and BE-22179: Establishment of Relative and Absolute Stereochemistry.

  2000cited by this paper
• Tumour markers in neuroendocrine tumours.

  1999cited by this paper
• Medical progress : Carcinoid tumors

  1999cited by this paper
• Notch signaling: cell fate control and signal integration in development.

  1999cited by this paper
• Carcinoid tumors.

  1999cited by this paper
• Mode of action of thiocoraline, a natural marine compound with anti-tumour activity

  1999cited by this paper
• Notch Signaling : Cell Fate Control and Signal Integration in Development

  1999cited by this paper
• Biological activity of thiocoraline, a novel marine depsipeptide

  1997cited by this paper
• Human achaete-scute homolog-1 is highly expressed in a subset of neuroendocrine tumors.

  1997cited by this paper
• Thiocoraline, a novel depsipeptide with antitumor activity produced by a marine Micromonospora. II. Physico-chemical properties and structure determination.

  1997cited by this paper
• Thiocoraline, a new depsipeptide with antitumor activity produced by a marine Micromonospora. I. Taxonomy, fermentation, isolation, and biological activities.

  1997cited by this paper
• Characterization of a Human Pancreatic Carcinoid in Vitro: Morphology, Amine and Peptide Storage, and Secretion

  1994cited by this paper

• The bisintercalator family of nonribosomal peptides: structural diversity and biosynthetic mechanism.

  2025cites this paper
• Exploring Cell Competition for the Prevention and Therapy of Esophageal Squamous Cell Carcinoma.

  2023cites this paper
• Micromonospora: A Prolific Source of Bioactive Secondary Metabolites with Therapeutic Potential.

  2022cites this paper
• Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review

  2022cites this paper
• Notch signaling pathway: architecture, disease, and therapeutics

  2022cites this paper
• Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors

  2021cites this paper
• Ex Vivo Modeling of Human Neuroendocrine Tumors in Tissue Surrogates

  2021cites this paper
• Notch Signaling in Embryology and Cancer: Notch Signaling in Cancer

  2021cites this paper
• Notch Signaling in Thyroid Cancer.

  2020cites this paper
• NOTCH and Esophageal Squamous Cell Carcinoma.

  2020cites this paper
• Antitumor Microbial Products by Actinomycetes Isolated from Different Environments

  2020cites this paper
• MARINE NATURAL PRODUCTS WITH HIGH ANTICANCER ACTIVITIES.

  2020cites this paper
• Thiocoraline mediates drug resistance in MCF-7 cells via PI3K/Akt/BCRP signaling pathway

  2019cites this paper
• The Role of Notch3 in Cancer.

  2018cites this paper
• Accessing Marine Microbial Diversity for Drug Discovery

  2017cites this paper
• Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets

  2017cites this paper
• Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1

  2017cites this paper
• Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo

  2017cites this paper
• Activation and Loading of the Starter Unit during Thiocoraline Biosynthesis.

  2017cites this paper
• AB3-Loaded and Tumor-Targeted Unimolecular Micelles for Medullary Thyroid Cancer Treatment.

  2017cites this paper
• Marine actinobacteria as a drug treasure house.

  2017cites this paper
• Peptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of Natural Sources for Pharmaceutical Applications

  2017cites this paper
• PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery.

  2016cites this paper
• Recent progress on the development of antibiotics from the genus Micromonospora

  2016cites this paper
• Marine Depsipeptides as Promising Pharmacotherapeutic Agents.

  2016cites this paper
• Single-molecule kinetics and footprinting of DNA bis-intercalation: the paradigmatic case of Thiocoraline

  2015cites this paper
• Chrysin suppresses the achaete-scute complex-like1 and alters the neuroendocrine phenotype of carcinoids

  2015cites this paper
• Marine Peptides: Bioactivities and Applications

  2015cites this paper